Author:
Zis Panagiotis,Chaudhuri Kallol Ray,Samuel Michael
Reference87 articles.
1. Barbeau A. L-dopa therapy in Parkinson’s disease: a critical review of nine years’ experience. Can Med Assoc J. 1969;101(13):59–68.
2. Schwab RS, England AC. Medical and surgical therapy of Parkinson’s disease. In: Fields WS, Charles C, editors. Pathogenesis and treatment of parkinsonism. Springfield: Thomas Publisher; 1958. p. 203.
3. Carlsson A, Lindqvist M, Magnusson T, Waldeck B. On the presence of 3-hydroxytyramine in brain. Science. 1958;127(3296):471.
4. Carlsson A. The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev. 1959;11(2 Part 2):490–3.
5. Ehringer H, Hornykiewicz O. Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr. 1960;38:1236–9.